Pancreatic Cancer Research

ResearcherUniversity of Illinois ChicagoNo recent work listed

Christopher S. Gondi

ORCID-verified (high confidence)As of 10 November 2026

Matched on ORCID iD 0000-0002-3036-9920; OpenAlex author ID A5110995347.

Their work

Papers
6 (first author 0, last author 6)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper

Papers 6

  1. Chemoresistance in pancreatic cancer: Emerging concepts. Last author DOI 10.3892/ol.2017.5777↗
  2. The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review). Last author DOI 10.3892/ijo.2016.3417↗
  3. Brief overview of selected approaches in targeting pancreatic adenocarcinoma. Last author DOI 10.1517/13543784.2014.902933↗
  4. Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. Last author DOI 10.1091/mbc.e12-04-0306↗
  5. Drugs in preclinical and early-stage clinical development for pancreatic cancer. Last author DOI 10.1517/13543784.2012.651124↗
  6. Suppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cells. Last author DOI 10.1158/1541-7786.mcr-10-0452↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Manu Gnanamony · 2 shared papers, 2016–2017
  2. Swapna Asuthkar · 3 shared papers, 2011–2013
  3. Monica K. Rossi · 1 shared paper, 2016
  4. Wesley R. Samore · 1 shared paper, 2014
  5. Bharathi Gorantla · 1 shared paper, 2011

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.